Clearmind Medicine Announces International Patent Application for Preventing and Treating Depression March 27, 2024
Kintara Therapeutics Announces Expansion of REM-001 Clinical Study to Include Patients on Pembrolizumab March 27, 2024
Vaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules March 27, 2024